MiraxBioPharma

MiraxBioPharma, formerly known as Mirax Pharma, is a Russian pharmaceutical company dedicated to the development and production of innovative medicinal products for women's reproductive health and oncology. Established in 2003, the company focuses on translating scientific research into proprietary treatments, particularly those based on indole derivatives like indole-3-carbinol and diindolylmethane. Its flagship products include Indinol Forto, a specialized drug for mastopathy and cyclic mastalgia, and Cervicon-DIM, a unique pharmacological agent for treating cervical intraepithelial neoplasia. MiraxBioPharma operates as a full-cycle pharmaceutical enterprise with a state-of-the-art manufacturing facility located in the Kaluga pharmaceutical cluster. The company's R&D programs target the molecular pathways involved in tumor growth and viral oncogene expression, addressing significant unmet needs in gynecological oncology.